Date: April 29, 2011
Contact: Kelly Griffith, Marketing Manager
Phone: (612) 492-7514
Email: kgriffith@fredlaw.com

For Immediate Release

Fredrikson & Byron Represents RXi Pharmaceuticals
in Acquisition of Apthera, Inc.

Minneapolis, MN April 29, 2011 – – Fredrikson & Byron acted as legal counsel for RXi Pharmaceuticals Corporation (Nasdaq: RXII) in its acquisition of Apthera, Inc. The transaction was closed on April 13, 2011. Fredrikson’s legal team included Christopher Melsha, Rhona Shwaid, and Sean Nagle.

Read RXi Pharmaceuticals Corporation’s press release.

RXi Pharmaceuticals Corporation is a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies.

Fredrikson & Byron is a 240 attorney law firm based in Minneapolis, with offices in Bismarck, Des Moines, Fargo, Monterrey, Mexico, and Shanghai, China. We’ve built a reputation as the firm “where law and business meet” by bringing business acumen and entrepreneurial thinking to our work with clients, and by operating as business advisors and strategic partners as well as legal counselors. The firm’s primary areas of practice include advertising, banking, corporate, corporate governance, employment and labor, energy and renewable energy, government relations, healthcare, intellectual property, international, life sciences, litigation, mergers & acquisitions, real estate, securities, and tax. We serve a broad range of clients, including multinational corporations, public companies, privately-held businesses, entrepreneurs, government agencies, and family businesses. Fredrikson & Byron’s attorneys also work with individuals on estate planning, family law, and immigration matters. We are the exclusive Minnesota law firm member of the World Services Group, a worldwide network of professional service providers. More information about the firm is available at www.fredlaw.com.